Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Explore which index funds have the lowest fees for retirement in 2024 and how expense ratios impact long-term growth. This intro explains why fee selection matters.
27,284 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
A four-name AI momentum basket — NVIDIA, AMD, Palantir and TESLA — drives 2027–2029 price targets as AI demand and EV...
Jefferies positions Amazon as the leading Mag 7 stock headed into earnings, underscoring AWS momentum, Prime Day stre...
Apple is leaning into a capital-light AI model that runs on-device and with trusted partners. This story explains why...
Unlock the signals behind American Water Works earnings calls. Learn how to read the transcript, spot growth drivers,...
When a feud becomes a marketing engine, money talks louder than records. This feature examines how T.I. targets Cent ...
Snowflake reported a stronger-than-expected quarter, with revenue and EPS above estimates and AI-driven monetization ...
Explore how Permian Resources could navigate 2025 earnings, debt reduction, and growth opportunities. Learn who benef...
Fairway Home Mortgage elevates Holly Mattson to co-president of recruiting to accelerate onboarding of loan producers...
A practical guide to understanding Fuel Tech (FTEK) in 2025. Learn what to watch in Q4 results, identify catalysts, a...
February brought a sharp setback for C3.ai investors. This article explains why shares C3.ai stock fell, what it mean...
Oracle stunned traders with a solid earnings beat and optimistic long-term guidance, fueling a surge in after-hours a...